// App-Quantinova.ai

e14555 : PD-L1 status in esophageal carcinoma at the mRNA and protein level.

Researchers

Presenter

  • Lars Tharun

Principal Investigators

  • Andreas H. Scheel

  • Thomas Zander

  • Hakan Alakus

  • Reinhard Buettner

  • Alexander Quaas

Medical Centers

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  • Department 1 for Internal Medicine, Center for Integrated Oncology Koln-Bonn, University Hospital Cologne, Cologne, Germany

  • Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Oral cancer

  • Esophageal Cancer

Biomarkers

  • Programmed death-ligand 1

  • Serpin B3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved